Skip to main content
Have a personal or library account? Click to login
Diagnostic Markers for Early Sepsis Diagnosis in Children With Systemic Inflammatory Response Syndrome Cover

Diagnostic Markers for Early Sepsis Diagnosis in Children With Systemic Inflammatory Response Syndrome

Open Access
|Nov 2009

References

  1. Angus, D.C., Yang, L., Kong, L., Kellum, J.A., Delude, R.L., Tracey, K.J., Weissfeld, L., GenIMS Investigators. (2007). Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.,, 1061-1067.
  2. Ballou, S.P., Kushner, I. (1992). C-reactive protein and the acute phase response.,, 313-336.
  3. Berner, R., Furll, B., Stelter, F., Drose, J., Muller, H.P., Schutt, C. (2002). Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis.,, 440-445.
  4. Blairon, L., Wittebole, X., Laterre, P.F. (2003). Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections.,, 287-291.
  5. Brilli, R.J., Goldstein, B. (2005). Pediatric sepsis definitions: Past, present, future.,(Suppl 3), 6-8.
  6. Carcillo, J.A., Planquois, J.S., Goldstein B. (2006). Early markers of infection and sepsis in newborns and children.,, 118-125.
  7. Carvalho, P.R.A., Feldens, L., Seitz, E.E., Rocha, T., Soledade, M., Trotta, A. (2005). Prevalence of systemic inflammatory syndromes at a tertiary pediatric intensive care unit.,, 2.
  8. Casado-Flores, J., Blanco-Quiros, A., Asesnsio, J., Arranz, E., Garrote, J., Nieto, M. (2003). Serum procalcitonin in children with suspected sepsis: A comparison with C reactive protein and neutrophil count.,, 190-195.
  9. Dahmet, M.K., Randolph, A., Viatli, S., Quasney, M.Q. (2005). Genetic polymorphisms in sepsis.,(Suppl 3), 61-73.
  10. Froon, A.H., Bemelmans, M.H., Greve, J.W., van der Linden, C.J., Buurman, W.A. (1994). Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values.,, 803-809.
  11. Gaini, S., Koldkjar, O.G., Moller, H.J., Pedersen, C., Pedersen, S.S. (2007a). A comparison of high-mobility group box-1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community - acquired infections and bacteraemia: A prospective study.,, R76.
  12. Gaini, S., Koldkjar, H., Pedersen, C., Pedersen, SS. (2006). Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: A prospective study.,, R53
  13. Gaini, S., Pedersen, S.S., Koldkjar, O.G., Pedersen, C., Moller, H.J. (2007b). High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: A prospective study.,, R32.
  14. Gardovska, D., Laizāne, G., Grope, I. (2001). Sepsis outcomes and early diagnostic peculiarities in tertiary level Children's hospital in Latvia.Riga, pp. 77-83.
  15. Goldstein, B., Giroir, B., Randolph, A., and the members of the International Consensus Conference on Pediatric Sepsis (2005). International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics.,(Suppl 3), 2-8.
  16. Guven, H., Altintop, L., Baydin, A., Esen, S., Aygun, D., Hokelek, M., Doganay, Z., Bek, Y. (2002). Diagnostic value of procalcitotin levels as early indicator of sepsis.,(3), 202-206.
  17. Hatada, T., Wada, H., Nobori, T., Okabayashi, K., Maruyama, K., Abe, Y., Uemoto, S., Yamada, S., Maruyama, I. (2005). Plasma concentrations and importance of High Mobility Group Box1 protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.,, 975-979.
  18. Hatherill, M., Tibby, SM., Sykes, K., Turner, C., Murdoch IA (1999). Diagnostic markers of infection: Comparison of procalcitonin with C reactive protein and leucocyte count.,, 417-421.
  19. Kocabas, E., Sarikcioglu, A., Aksaray, N., Seydaaaaoglu, A. (2007). Role of procalcitonin, C reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor alfa in the diagnosis of neonatal sepsis.,, 7-20.
  20. Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.L., Ramsay, G. (2003). International Sepsis Definitions Conference.,, 530-538.
  21. Meisner M. (2005). Biomarkers of sepsis: Clinical useful?,, 473-480.
  22. Mishra, K., Jacobs, S.E., Doyle, L.W., Garland S.M. (2006). Newer approaches to the diagnosis of early onset neonatal sepsis.,(3), F208-212.
  23. Fink, M.P, (2007). Bench-to-bedside review: High-mobility box 1 and critical illness.,, 229.
  24. Miyaoka, K., Iwase, M., Suzuki, R., Kondo, G., Watanabe, H., Ito, D., Nagumo, M. (2005). Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation.,, 144-150.
  25. Mokart, D., Merlin, M., Sannini, A. (2005). Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): Early markers of postoperative sepsis after major surgery.,, 767-773.
  26. Ng, P.C., Lam, H.S. (2006). Diagnostic markers for neonatal sepsis.,, 125-131.
  27. Ng, P.C., Li, K., Wong, R.P. (2003). Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections.,, F209-213.
  28. Oda, S., Hirasawa, H., Shiga, H., Nakanishi, K., Matsuda, K., Nakamua, M. (2005). Sequential measurements of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis.,, 169-175.
  29. Pan, D.J., Chen, D., Li, Y. (2003). Serum procalcitotin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin.(Eng).,, 538-542.
  30. Pavcnik-Arnol, M., Hojker, S., Derganc, M. (2004). Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: Comparison with procalcitonin, interleukin-6, and C-reactive protein.,, 1454-1460.
  31. Pavcnik-Arnol, M., Hojker, S., Derganc, M. (2007). Lipopolysaccharide-binding protein, lipopolysaccharide, and soluable CD14 in sepsis of critical ill neonates and children.,, 1025-1032.
  32. Proulx, F., Fayon. M., Farrell, C.A., Lacroix, J., Gauthier, M. (1996). Epidemiology of sepsis and multiple organ dysfunction syndrome in children.,, 1033-1037.
  33. Randolph, A.G. (2005). The purpose of the 1st International Sepsis Forum on Sepsis in Infants and Children.,(Suppl 3), S1-S2.
  34. Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, SC., Wenz, R.P. (1995). The natural history of systemic inflammatory response syndrome (SIRS): A prospective study.,, 117-123.
  35. Rey, C., Los, Arcos M., Concha, A., Medina, A., Prieto, A. (2007). Pro-calcitonin and C reactive proteine as markers of systemic inflammatory response syndrome severity in critically ill children., 447-454.
  36. Rich, F.C., Cholley, B.P., Panis, Y.H., Laisne, M.J., Briard, C.G., Graulet, A.M. (2000). Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.,, 443-447.
  37. Silveira, R.C., Procionoy, R.S. (1999). Evaluation of interleukin-6, tumor necrosis factor-alpha and interleukin-1 beta for early diagnosis of neonatal sepsis.,, 647-650.
  38. Sunden-Cullberg, J., Norrby - Teglund, A., Rouhianen, A., Rauvala, H., Herman, G., Tracey, K.J., Lee, M.L., Andersson, J., Tokics, L., Treutiger, C.J. (2005). Persistent elevation of high mobility group box -1 protein (HMGB1) in patients with severe sepsis and septic shock.,, 564-573.
  39. Sunden-Cullberg, J., Norrby-Teglund, A., Teutiger, C.J. (2006). The role of high mobility group box-1 protein in severe sepsis.,, 231-236.
  40. Thayyil, S., Shenoy, M., Hamaluba, M., Gupta, A., Frater, J. (2005). Is procalcitonin is useful in early diagnosis of serious bacterial infections in children?, 155-158.
  41. Ubenauf, K.M., Krueger, M., Henneke, P., Berner, R. (2007). Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children., 159-162.
  42. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellio, M., Che, J., Frasier, A., Yang, H., Ivanova, S., Borovikova, L. (1999). HMGB-1 as a late mediator of endotoxin lethality in mice.,, 248-251.
  43. Wang, H., Vishnubhakat, JM., Bloom, O. (1999). Proinflammatory cytokines (tumor necrosis factor and interleukin1) stimulates release of high mobility group protein 1 by pituicytes.,, 389-392.
  44. Watson, R.S., Carcillo, J.A. (2005). Scope and epidemiology of pediatric sepsis.,(Suppl 3), 3-4.
  45. Watson, R.S., Carcillo, J.A., Linde-Zwirble, W.T., Clermont, G., Lidicker, J., Angus, D. (2003). The epidemiology of severe sepsis in children in the United States.,, 695-701.
  46. Yang, H., Ochani, M., Li, J., Tanovic, M., Harris, H.E., Susarla, S., Ulloa, L., Wang, H., DiRaimo, R., Czura, C.J. (2004). Reversing established sepsis with antagonists of endogenous HMGB1., 296-301.
  47. Yasuda, T., Ueda, T., Takeyama, Y., Shinzeki, M., Sawa, H., Nakajima, T., Ajiki, T., Fujino, Y., Suzuki, Y., Kuroda Y. (2006). Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.,, 359-363.
DOI: https://doi.org/10.2478/v10046-009-0048-z | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 191 - 197
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2009 Jana Pavāre, Ilze Grope, Imants Kalniņš, Dace Gardovska, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.